Proof in the Pudding: The Value of a Rights Based Approach to Understanding the Covert Administration of Psychotropic Medication to Adult Inpatients Determined to Be Decisionally-Incapable in Ontario's Psychiatric Settings
Restricted accessResearch articleFirst published online June, 2017
Proof in the Pudding: The Value of a Rights Based Approach to Understanding the Covert Administration of Psychotropic Medication to Adult Inpatients Determined to Be Decisionally-Incapable in Ontario's Psychiatric Settings
This paper explores a grey area of psychiatric practice and, as with other challenging practices, the law is called upon to navigate conflicting legal issues. In particular, this paper explores the covert administration of medication: the concealment of medication in food or drink so that it will be consumed undetected. Rights-based approaches support nuanced understanding of the practices. Few policies, protocols or guidelines govern the practice in Ontario's psychiatric settings. While covert medication is understood to have “something to do” with rights, there is confusion about how those rights play out on the ground. Institutional silences underlie and reinforce the practice. Most pressing, the covert administration of medication warrants an overt discussion, including of its impact on the rights-experience of persons in psychiatric settings.
J.Stubbs, C.Haw, and G.Dickens, “Dose Form Modification: A Common but Potentially Hazardous Practice: A Literature Review and Study of Medication Administration to Older Psychiatric Inpatients,”International Psychogeriatrics20, no. 3 (2008): 616-627.
3.
A.Levin, “Covert Drug Administration: Win Battle, But Lose War,”Psychiatric Services40, no. 10 (2005): 10-13.
4.
P.Whitty and P.Devitt, “Surreptitious Prescribing in Psychiatric Practice,”Psychiatric Services56, no. 4 (2005): 481-483.
5.
D. C.Donat, “Encouraging Alternatives to Seclusion, Restraint, and Reliance on PRN Drugs in a Public Psychiatric Hospital,”Psychiatric Services56, no. 9 (2005): 1105-1108.
6.
See, for example, T.Blackwell, “When Doctors Hide Pills in a Patient's Food, Is It a Breach of Trust or a ‘Practical Way’ to Ensure They Take Their Medicine?”National Post, June26, 2013. See also J. Brean, “Ruling Says Hospital Can't Force Anti-psychotic Drug on Patient after Questionable Schizophrenia Diagnosis,” National Post, July 31, 2013. In addition, a section of a recent issue of the Indian Journal of Psychiatry was devoted to covert medication.
7.
L.Honkanen, “Point-Counterpoint: Is It Ethical to Give Drugs Covertly to People with Dementia? No: Covert Medication Is Paternalistic,”Western Journal of Medicines174 (2001): 229. See also L. Ahern and L. Van Tosh, “The Irreversible Damage Caused by Surreptitious Prescribing,” Psychiatric Services 56, no. 4 (2005): 383. See also E. Lynn and K. Rios, “Covert Administration of Psychotropic Medications in the Emergency Department: An Opposing View,” Annals of Emergency Medicine 48, no. 4 (2006): 478.
8.
S.Stroup, M.Swartz, and P.Appelbaum, “Concealed Medicines for People with Schizophrenia: A U.S. Perspective,”Schizophrenia Bulletin28, no. 3 (2002): 537-542.
9.
J.Wong, Y.Poon, and E.Hui, “I Can Put the Medicine in His Soup, Doctor!”Journal of Medical Ethics31, no. 5 (2005): 262-265. See also M. R. Lewin, L. Montauk, M. Shalit, and F. Nobay, “An Unusual Case of Subterfuge in the Emergency Department: Covert Administration of Antipsychotic and Anxiolytic Medications to Control an Agitated Patient,” Annals of Emergency Medicine 47, no. 1 (2006): 75-78.
10.
See, e.g., T. N.Srinivasan and R.Thara, “At Issue: Management of Medication Noncompliance in Schizophrenia by Families in India,”Schizophrenia Bulletin28, no. 3 (2002): 531-535.
B. M.Meier, L.Gable, J. E.Getgen and L.London, “Rights Based Approaches to Public Health Systems,” in E.Beracochea, C.Weinstein, and D.Evans, eds., Rights Based Approaches to Public Health (New York: Springer Publishing, 2010): 19-30, at 19.
13.
See, for example, L.Lundy and L.McEvoy, “Developing Outcomes for Education Services: A Children's Rights-Based Approach,”Effective Education1, no. 1 (2009): 43-60.
14.
M.Chilton and D.Rose, “A Rights-Based Approach to Food Insecurity in the United States,”American Journal of Public Health99, no. 7 (2009): A1203 — 1211.
15.
D.Barr, J. J.Amon, and M.Clayton, “Articulating A Rights-Based Approach to HIV Treatment and Prevention Interventions,”Current HIV Research9, no. 6 (2011): 396-404.
16.
Office of the High Commissioner for Human Rights, Monitoring the Convention on the Rights of Persons with Disabilities: Guidance for Human Rights Monitors - Professional Training Series No 17 (New York and Geneva: OHRCHR, 2010).
17.
Law Commission of Ontario, Framework for the Law as it Affects Persons with Disabilities (Toronto: Law Commission of Ontario, 2012), available at <www.lco-cdo.org/en/content/persons-disabilities> (last visited May 1, 2017).
18.
Id., at 112.
19.
Constitution Act, 1982, Schedule B to the Canada Act 1982 (UK), 1982, c 11 at s 52 [Charter].
20.
International Convention on the Rights of Persons with Disabilities, GA Res 31/82, GAOR, 7th Sess., Annex II, UN Doc A/RES/61/106 (13 December 2006) [CRPD].
21.
LCO Framework (2012) supra note 17, at 3.
22.
Id., at 100.
23.
Id., at 211.
24.
E. K.Hung, D. E.McNiel, and R. L.Binder, “Covert Medication in Psychiatric Emergencies: Is It Ever Ethically Permissible?”Journal of the American Academy of Psychiatry and the Law40, no. 2 (2012): 239-245, at 244.
25.
Health Care Consent Act, RSO 1996, c 2 at s 10 (1) [HCCA].
26.
Id., at s 4(1).
27.
Id., at s 4(2).
28.
Id., at s 15(1).
29.
Id., at s 15(2).
30.
Id., at at s 10(1).
31.
Id., at s 20(1).
32.
Id., at s 21: “Principles for giving or refusing consent”.
33.
Id., at s 37.
34.
Substitute Decisions Act, 1990, RSO 1990, c. 30 at s 6 [SDA].
35.
Id., at s 45.
36.
Mental Health Act, RSO 1990, cM7 [MHA].
37.
Id., at s 53.
38.
See Charter, supra note 19 at s 52.
39.
McKinney v University of Guelph, [1990] 3 SCR 229 (Lexum). Stoffman v Vancouver General Hospital, [1990] 3 SCR 483 (Lexum); Eldridge v British Columbia (Attorney General), [1997] 3 SCR 624 (Lexum); M.Jackman, “The Application of the Canadian Charter in the Health Care Context,”Health Law Review9, no. 2 (2001): 22-26; M. Jackman, “Charter Review as a Health Care Accountability Mechanism in Canada,” Health Law Journal 18 (2010): 1-29.
40.
G.Monticone, “Using Restraints in Long-Term Care Facilities: Does the Charter of Rights Mean that Long Term Care Facilities Must Change their Practices?” (Spring 2000) ACE Newsletter, vol. 3, no. 1, available at <http://advocacycentreelderly.org/appimages/file/restraints.pdf> (last visited May 1, 2017).
41.
L.Gostin and L.Gable, “The Human Rights of Persons with Mental Disabilities: A Global Perspective on the Application of Human Rights Principles to Mental Health,”Maryland Law Review63 (2004): 20-121, at 115.
42.
See Office of the High Commissioner for Human Rights, supra note 16, at 13.
Office of the High Commissioner for Human Rights, supra note 42, at 19.
45.
CRPD, supra note 20, at Preamble (n).
46.
Id., at Article 3.
47.
Office of the High Commissioner for Human Rights, supra note 42, at 19.
48.
A.Dhanda, “Legal Capacity in the Disability Rights Convention: Stranglehold of the Past or Lodestar for the Future,”Syracuse Journal of International Law and Commerce34 (2007): 429-462.
Office of the High Commissioner for Human Rights, supra note 42, at 26.
51.
Id., at 26.
52.
See CRPD, supra note 20, at Article 25 (“Health”).
53.
See Office of the High Commissioner for Human Rights, supra note 42, at 27 [emphasis added].
54.
Id., at 26.
55.
M. L.Perlin and M.Schriver, “‘You That Hide Behind Walls’: The Relationship between the Convention on the Rights of Persons with Disabilities and the Convention against Torture and the Treatment of Institutionalized Forensic Patients,” in Torture in Healthcare Settings: Reflections on the Special Rapporteur on Torture's 2013 Thematic Report (Washington: American University Washington College of Law, 2014): 195-218, available at <antitorture.org/wp-content/uploads/2014/03/PDF_Torture_in_Healthcare_Publication.pdf> at 195; J.E. Lord, “Shared Understanding or Consensus-Masked Disagreement? The Anti-Torture Framework in the Convention on the Rights of Persons with Disabilities,” Loyola of Los Angeles International and Comparative Law Review 33 (2010): 27-81, at 29ff.
56.
Convention against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment, 10 December 1984, 1465 UNTS 113, 19 ILM 33 (entered into force 26 June 1987).
57.
Report of the Special Rapporteur on Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment, HRC, 22nd Session, UN Doc A/HCR/22/53 (1 February 2013), at paras 1 and 66.
58.
Chaudry (Re) [2007] ORBD No 224 (QL) (Ontario Review Board) at para 12.
59.
Koundakjian (Re), [2010] ORBD No 1759 (QL) (Ontario Review Board) at para 22.
60.
Anten v Bhalerao, 2013 ONCA 499, [2013] OJ No 3459, 309 OAC 28, 366 DLR (4th) 370, 229 ACWS (3d) 870 (QL) (Court of Appeal) at para 9.
PS (Re), [2004] OCCBD No 10 (QL) (Ontario Review Board).
63.
W (Re), [2005] OCCBD No 234 (QL)(Ontario Review Board) at para 15.
64.
SMT v Abouelnasr, [2008] OJ No 1298, 171 CRR (2d) 344, 166 ACWS (3d) 569 (QL) (Sup Ct).
65.
Canadian Nurses Association, Code of Ethics for Registered Nurses (Ottawa: CNA, 2008), available at <cna-aiic.ca/en/on-the-issues/best-nursing/nursing-ethics> (last visited May 2, 2017): at 17: “F3. Nurses do not engage in any form of lying, punishment or torture or any form of unusual treatment or action that is inhumane or degrading.”
Royal College of Psychiatrists United Kingdom, “College Statement on Covert Administration of Medicines,”Psychiatric Bulletin28 (2004): 385-386, at 386.
71.
LCO Framework (2012), supra note 17, at 94.
72.
Id., at 66.
73.
See Charter, supra note 19, at s. 15.
74.
See CRPD, supra note 20, at Article 5 (“Equality and Non-discrimination).
75.
See CRPD, supra note 20, at Article 25 (“Health”).
76.
Honourable Chief JusticeBeverleyMcLachlin, “Medicine and the Law: The Challenges of Mental Illness,”Dalhousie Law Journal33 (2010): 15-33, at 20.
77.
H. A.Kaiser, “Restraint and Seclusion in Canadian Mental Health Facilities: Assessing the Prospects for Improved Access to Justice,”Windsor Yearbook Access to Justice19 (2001): 391-417, at 391.
78.
J.M.Kilty, “Governance through Psychiatrization: Seroquel and the New Prison Order,”Radical Psychology2, no. 1 (2008): 2-5, at 4.
O.Kirkevold and K.Engedal, “Concealment of Drugs in Food and Beverages in Nursing Homes: Cross Sectional Study,”BMJ330, no. 7481 (2005): 20-22.
81.
J. A.Duxbury, K.Wright, D.Bradley, and P.Barnes, “Administration of Medication in the Acute Mental Health Ward: Perspective of Nurses and Patients,”International Journal of Mental Health Nursing19, no. 1 (2010): 53-61, at 58.
82.
See LCO Framework (2012), supra note 17, at 71.
83.
Id., at 71.
84.
L.Gable and L. O.Gostin, “Mental Health as a Human Right,”Swiss Human Rights BookIII (2009): 249-261, at 251.
85.
R v Swain, [1991] 1 SCR 933 (Lexum) (Supreme Court of Canada) at para 994. See also Nova Scotia (Workers' Compensation Board) v Laseur, [2003] 2 SCR 504 (Lexum) (Supreme Court of Canada) at para 90.
86.
See Kaiser (2001), supra note 77, at 391.
87.
See LCO Framework (2012), supra note 17, at 14.
88.
See LCO Framework (2012), supra note 17, at 3.
89.
N. N.Bock, R. M.Sales, T.Rogers, and B.DeVoe, “A Spoonful of Sugar: Improving Adherence to Tuberculosis Treatment Using Financial Incentives,”International Journal of Tuberculosis and Lung Disease5, no. 1 (2001): 96-98.
90.
S.Pereira, D.Beer, and C.Paton, “Enforcing Treatment with Clozapine: Survey of Views and Practice,”Psychiatric Bulletin23, no. 6 (1999): 342-345.
91.
D.Claassen, W. K.Fakhoury, R.Ford, and S.Priebe, “Money for Medication: Financial Incentives to Improve Medication Adherence in Assertive Outreach,”Psychiatric Bulletin31 (2007): 189-193. See also A. Giufrrida and D. J. Torgerson, “Should We Pay the Patient? Review of Financial Incentives to Enhance Patient Compliance,” BMJ 315, no. 7110 (1997): 703-707.
92.
G. W.Currier and M. H.Allen, “Physical and Chemical Restraint in the Psychiatric Emergency Service,”Psychiatric Services51, no. 6 (2000): 717-719.
93.
See CRPD, supra note 20, at Article 3 (“General Principles”).
94.
See HCCA, supra note 25, at s 21(1).
95.
See HCCA, supra note 25, at s 21(2)(b).
96.
R.Solomon, J.Gray, R.O'Reilly, and M.Nikolic, “Treatment Delayed - Liberty Denied,”Canadian Bar Review87, no. 3 (2009): 679-719, at 681.
97.
Government of Canada, The Human Face of Mental Health and Mental Illness in Canada 2006 (Ottawa: Minister of Public Works and Government Services, 2006): at 47.
98.
LCO Framework (2012), supra note 17 at 112.
99.
See, e.g., A. P.Morrison, P.Hutton, D.Shiers and D.Turkington, ”Antipsychotics: Is It Time to Introduce Patient Choice?”British Journal of Psychiatry201 (2012): 83-84.
100.
G. F.Lorem, J. S.Frafjord, M.Steffensen, and C. E.Wang, “Medication and Participation: A Qualitative Study of Patient Experiences with Antipsychotic Drugs,”Nursing Ethics21, no. 3 (2013): 347-358, at 348.
101.
See LCO Framework (2012), supra note 17, at 82.
102.
See Mental Welfare Commission for Scotland (2013), supra note 68, at 4.
S.Sherwin, “A Relational Approach to Autonomy in Health Care,” in S.Sherwin, ed., The Politics of Women's Health: Exploring Agency and Autonomy (Philadelphia: Temple University Press, 1998): 19-47, at 38.
107.
See LCO Framework (2012), supra note 17.
108.
Id., at 3.
109.
Id., at 94.
110.
See Royal College UK (2004), supra note 70, at 385.
111.
Report of the Special Rapporteur on the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health, UNGAOR, 64 Sess, UN Doc A/64/272 (10 August 2009) at para 18. See aso the Report of the Special Rapporteur on Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment, HRC, 22nd Session, UN Doc A/HCR/22/53 (1 February 2013) at para 28 [ Special Rapporteur — Torture (2013)].
See Royal College UK (2004), supra note 70: “In an incapacitated adult, repeated restraint and injection of treatment (with attendant risk to life) may well be more degrading and inhuman than the covert administration of medication.”
114.
See, e.g., J.Scott and E.Williams, “Concealed Administration of Drug Treatment May Represent Thin End of the Wedge,”BMJ315, no. 25 (1997): 300-301, at 300.
115.
See Charter, supra note 19, at s 12: “Everyone has the right not to be subjected to any cruel and unusual treatment or punishment.”
116.
See CRPD, supra note 20, at Article 15.
117.
See Special Rapporteur — Torture (2013) supra note 110.
118.
Id., at para 64.
119.
Id.
120.
See HCCA, supra note 25, at s 7.
121.
See, e.g., Stewart v Extendicare Ltd, [1986] SJ 419, (1986) 4 WWR 559, (1986) 38 CCLT67, (1986) 48 Sask R 86 (QL) (Sask QB).
122.
Wellesley Hospital v Lawson, [1978] 1 SCR 893 (Lexum) at 899.
123.
See LCO Framework (2012), supra note 17, at 88.
124.
See CRPD, supra note 20, at “Preamble(w)”
125.
See Gable and Gostin (2009), supra note 84, at 8.
126.
See LCO Framework (2012), supra note 17, at 116.
127.
LCO Framework (2012), supra note 17, at 1.
128.
RM v St Andrew's Healthcare, 116 BMLR 72, [2010] UKUT 119 (AAC), (2010) 116 BMLR 72 (23 April 2010) (UK Upper Tribunal — Administrative Appeals Chamber) at 119.
129.
Royal College UK (2004), supra note 70, at 9.
130.
M.Perlin, “International Human Rights and Comparative Mental Disability Law: The Role of Institutional Psychiatry in the Suppression of Political Dissent,”Israel Law Review36, no. 3 (2006): 71-97, at 85.
131.
L.Patton, “These Regulations Aren't Just Here to Annoy You: The Myth of Statutory Safeguards, Patient Rights and Charter Values in Ontario's Mental Health System,”Windsor Review of Legal and Social Issues25 (2008): 9-32, at 29.
132.
M.Bay, “Making the Law Match the Reality: Making the Reality Match the Law,”Journal of Ethics in Mental Health1, no. 1 (2006): 1-4, at 4: “In fact, I would argue that it would be better in many ways not to have any laws at all in these areas than to have laws that are ignored.”
133.
H. A.Kaiser, “Canadian Mental Health Law: The Slow Process of Redirecting the Ship of State,”Health Law Jounal17 (2009): 139-194, at 152.
134.
S. S.Silbey, “After Legal Consciousness,”Annual Review of Law and Social Sciences1 (2005): 323-368, at 323.
135.
B.Wojtowicz, B.Hagen-Van, and C.Daalen-Smith, “No Place to Turn: Nursing Students' Experiences of Moral Distress in Mental Health Settings,”International Journal of Mental Health Nursing23, no. 3 (2013): 257-264, at 261.
136.
L.Barnes, J.Cheek, R. L.Nation, A.Gilbert, L.Paradiso, and A.Ballantyne, “Making Sure the Residents Get their Tablets: Medication Administration in Care Homes for Older People,”Journal of Advanced Nursing56, no. 2 (2006): 190-199.
137.
A.Treloar, M.Philpot, and B.Beats, “Concealing Medication in Patients' Food,”The Lancet6, no. 9249 (2001): 62-64, at 62.
138.
A.Treloar, B.Beats, and M.Philpot, “A Pill in the Sandwich: Covert Medication in Food and Drink,”Journal of the Royal Society of Medicine93, no. 8 (2000): 408-411, at 410.
